The WATER IV Prostate Cancer: Aquablation Therapy Versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer

Sponsor:
PROCEPT BioRobotics
Sponsor Study ID:
CSP0005
CTO #:
104201
NCT Number:
NCT06651632
Phase:
N/A
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Prostate
Study Objectives:
To evaluate the safety and efficacy of Aquablation Therapy with the AQUABEAM Robotic System and the HYDROS Robotic System to reduce treatment related harm in men with Grade Group (GG) 1 to 3 localized prostate cancer who are candidates for, or have selected, prostatectomy.
eConsent:
Not available
Study Documents:
Open Study Documents
(MUSC NetID required for document access)

For more information about this trial please contact the study team:

  • Medical University of South Carolina

Trial opened at the following institutions:

Medical University of South Carolina